HHealth Read More Specialized blood vessel cells found to actively drive lung fibrosisAugust 29, 2026 Millions of people worldwide are affected by diseases that cause scarring of the lungs, often leading to breathing…
HHealth Read More Scientists Discover a Hidden Hormone Pathway That Protects the Liver From DamageAugust 19, 2026 Researchers found that GDF15 can shift liver immune activity toward a less inflammatory state and reduce scarring in…
HHealth Read More Natural hormone activates brain-to-liver signaling pathway to suppress liver inflammationAugust 10, 2026 Researchers at McMaster University have discovered that a naturally occurring hormone best known for suppressing appetite and promoting weight…
HHealth Read More Using DNA sequencing for accurate identification of microbial infections in cystic fibrosis patientsAugust 3, 2026 Lung infections are a constant risk for people living with cystic fibrosis (CF), a life-threatening genetic disorder which…
HHealth Read More Daily tomatoes lowered a key marker of liver fat in MASLD trialAugust 3, 2026 A six-week tomato-rich diet outperformed a tomato-free diet on an important marker of hepatic steatosis, pointing to a…
SScience Read More New project aims to systematically map billion cellular interactionsJune 23, 2026 Multicellular life depends on remarkable acts of cooperation. Every cell in the human body must sense what is…
HHealth Read More New insights into long-term liver injury after Kasai portoenterostomy for biliary atresiaJanuary 16, 2026 BA is characterized by early destruction of the bile ducts, leading to cholestasis, inflammation, and rapid fibrosis shortly…
GGenetics Read More New gene-editing method can correct many disease-causing mutations in mammalian cellsOctober 23, 2025 Some genetic disorders-such as cystic fibrosis, hemophilia and Tay Sachs disease-involve many mutations in a person’s genome, often…
MMedication Read More Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosisAugust 17, 2025 “Today’s decision by the FDA reflects the continued progress in how we understand and treat patients with MASH,…